TacticScale

What China Resources Pharmaceutical Does & How It Makes Money (3320.HK)

Updated October 2026 · reflects China Resources Pharmaceutical's latest reported financials

Chinese state-backed pharmaceutical maker, distributor and pharmacy operator. It earns money by selling its own branded medicines and health products, and by charging for wholesale distribution, warehousing and logistics services to hospitals, distributors and pharmacies.

China Resources Pharmaceutical's story, moat and numbers — in a 3-minute visual book.

Explore China Resources Pharmaceutical on TacticScale →

How China Resources Pharmaceutical makes money

It earns money by selling its own branded medicines and health products, and by charging for wholesale distribution, warehousing and logistics services to hospitals, distributors and pharmacies. Its retail pharmacies bring in additional sales.

What China Resources Pharmaceutical does

China Resources Pharmaceutical Group is an investment holding company, a subsidiary of CRH (Pharmaceutical) Limited, and covers the whole pharmaceutical value chain in Mainland China. It has four segments: manufacturing, distribution, retail, and others. On the manufacturing side, it makes chemical drugs, Chinese medicines, biological drugs and nutrition products. These cover a wide range of therapeutic areas, including cardiovascular, metabolic, respiratory, pediatric, antitumor, anti-infection, blood products and intravenous infusions. Its brands include 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya and Kun Zhong Yao. Its distribution arm supplies warehousing, logistics and supply chain services to drug and medical device makers and to hospitals, distributors and pharmacies. It also runs retail pharmacies, including stores under the Teck Soon Hong brand, and holds some property. The company was incorporated in 2007, is headquartered in Wan Chai, Hong Kong, and took its current name in 2011. Its former name was China Resources Medications Group.

Products & services

What is China Resources Pharmaceutical worth?

Fair value: not published

A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.

We show a fair value only when the method is trustworthy. See China Resources Pharmaceutical on TacticScale →

Sector Healthcare Industry Drug Manufacturers - Specialty & Generic HQ Hong Kong Ticker 3320.HK Official site

Related companies

China Resources Double-Crane Pharmaceutical (600062.SS) · China Resources Jiangzhong Pharmaceutical (600750.SS) · China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) · Shanghai Pharmaceuticals (601607.SS)